Also, THOR methylation proves to be of value in differentiating non-neoplastic (group 1, “normal” control tissue) from carcinoma, and, potentially, from recurrent PA tissue and parotid tissue adjacent to carcinoma and tissues adjacent to carcinoma and to PA. The gene discussed is THORLNC; the disease is carcinoma.